Navigation Links
Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting

reliance on any forward-looking statement. There are a number of important factors that could cause Cytogen's results to differ materially from those indicated by such forward-looking statements. In particular, Cytogen's business is subject to a number of significant risks, which include, but are not limited to Cytogen's ability to successfully execute strategic transactions for its technology platforms, as well as other factors expressed from time to time in Cytogen's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with Cytogen's periodic filings with the SEC. The statements contained herein are made only as of the date of this press release, and Cytogen undertakes no obligation to publicly update this information to reflect subsequent events or circumstances.

Contact

Media/Investors:
Cytogen Corporation
Susan M. Mesco, 609-750-8213


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
3. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
4. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
5. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
6. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
7. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
8. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
9. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
10. Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Societys Annual Meeting
11. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
Post Your Comments:
(Date:5/28/2015)...   Clementia Pharmaceuticals, Inc. today announced ... part (Part B) of its natural history study ... rare, severely disabling congenital myopathy characterized by painful, ... result in the formation of new, abnormal (heterotopic) ... The multi-center, non-interventional, two-part longitudinal study is ...
(Date:5/28/2015)... 2015 MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX), ... that its President and Chief Executive Officer, David ... Invitational Investor Conference being held at the Luxe ... on June 1-3, 2015. Mr. Hansen ... significant progress made in the last year and plans ...
(Date:5/28/2015)... , May 28, 2015  Caris Life Sciences®, ... promise of precision medicine, today announced the presentation ... demonstrate the utility of Caris Molecular Intelligence®, the ... mechanisms of drug resistance and pathway alterations in ... in poster sessions at the annual meeting of ...
Breaking Medicine Technology:Clementia Advances Natural History Study of Patients with Fibrodysplasia Ossificans Progressiva 2Clementia Advances Natural History Study of Patients with Fibrodysplasia Ossificans Progressiva 3MabVax Therapeutics Holdings to Present at the 2015 LD Micro Invitational Investor Conference on June 2nd at 4:30 PM EDT 2MabVax Therapeutics Holdings to Present at the 2015 LD Micro Invitational Investor Conference on June 2nd at 4:30 PM EDT 3MabVax Therapeutics Holdings to Present at the 2015 LD Micro Invitational Investor Conference on June 2nd at 4:30 PM EDT 4Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 2Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 3Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 4Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 5
... estimate that nearly one-third of cases of melanoma ... diagnosed in women during their childbearing years. Since many women ... with the fact that melanoma is the most common form ... could be faced with developing melanoma before or during pregnancy.At ...
... Up To $55 Million in Near Term Payments ... today announced that the company has entered into ... European rights to develop and commercialize the investigational ... syndrome with constipation (IBS-C) and other gastrointestinal conditions. ...
Cached Medicine Technology:Melanoma and Pregnancy: What Every Woman Needs to Know About the Risks, Prognosis 2Melanoma and Pregnancy: What Every Woman Needs to Know About the Risks, Prognosis 3Melanoma and Pregnancy: What Every Woman Needs to Know About the Risks, Prognosis 4Melanoma and Pregnancy: What Every Woman Needs to Know About the Risks, Prognosis 5Ironwood Announces Linaclotide European Licensing Agreement with Almirall 2Ironwood Announces Linaclotide European Licensing Agreement with Almirall 3
(Date:5/28/2015)... Optimity Advisors ( Optimity ) ... of care for healthcare organizations worldwide – today ... help operationalize contracting and engagement models. As part ... series of seven “ OrangePapers” that provide ... is a strategy, operations and information technology advisory ...
(Date:5/28/2015)... what your racquet can do for you but what kind ... the launch of their new digital campaign, HEAD introduces trick ... unique skill to HEAD Pro Players and consumers around the ... demonstrates how to gain more control over the racquet and ... tennis enthusiasts everywhere to join the show. , The digital ...
(Date:5/28/2015)... 2015 Although many people have resigned ... their slow metabolism for life, never being able to ... true. There are methods to jump start the metabolism. ... low-carbohydrate, low-fat and no-fat foods, cleverly worded to lure ... times the foods contain hidden ingredients and hidden ...
(Date:5/28/2015)... Aureus Medical Group (web: aureuslocumtenens.com), a national leader ... that it will participate as an exhibitor at the ... be held June 9-14, 2015 in New Orleans, Louisiana. ... and exhibits with products and services. , Representatives ... be available to speak with attendees about its full ...
(Date:5/28/2015)... 28, 2015 JJ Mowder-Tinney, PT, PhD, NCS, ... New York Physical Therapy Association (NYPTA) by the Delegation at ... member of the NYPTA. At the National level, she ... Section Research Committee and an abstract reviewer for the Neurology ... been a member of the Program committee since 2010 and ...
Breaking Medicine News(10 mins):Health News:Optimity Advisors Now Offers Outcomes Based Contracting Services to Support Engagement Model For New Healthcare Innovative Models of Care 2Health News:Tennis Artist Baffles Novak Djokovic - HEAD Launches Trick Shot Campaign “Frame & Play” 2Health News:As Part of their Comprehensive Weight Loss Program, Diet Doc Now Teaches Patients how to Identify Hidden Carbohydrates for Safe, Fast and Long Term Weight Loss Success 2Health News:As Part of their Comprehensive Weight Loss Program, Diet Doc Now Teaches Patients how to Identify Hidden Carbohydrates for Safe, Fast and Long Term Weight Loss Success 3Health News:As Part of their Comprehensive Weight Loss Program, Diet Doc Now Teaches Patients how to Identify Hidden Carbohydrates for Safe, Fast and Long Term Weight Loss Success 4Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the American Association of Nurse Practitioners’ 2015 National Conference 2
... 2 Responding to increased attention about clinical productivity ... Centric, Inc. ( www.usercentric.com ) - a ... a new service for the healthcare industry called ... providers. Among the technologies targeted for these service ...
... of a naturally fluorescent molecule found in all living ... according to bioengineers. , NADH, or nicotinamide adenine dinucleotide, ... for the functioning of an enzyme -- found mostly ... or mitochondria. It fuels a series of biochemical reactions ...
... Acquisition of BiotelCONSHOHOCKEN, Pa., April 2 CardioNet, Inc. ... technology company with an initial focus on the diagnosis ... into the cardiac clinical research services business and the ... The two companies entered into a binding definitive merger ...
... WASHINGTON, April 2 The following is a statement from ... (TFAH) in response to the release of the new report ... by the Robert Wood Johnson Foundation Commission to Build a ... healthy as he or she can be. And every ...
... of the Country,s Largest e-Prescribing Initiatives Drives Industry-leading Prescriber ... you recently went to your doctor and received a ... the rule. That,s right, in New Jersey more and ... pad in favor of e-prescribing technology that is improving ...
... PHILADELPHIA, April 2 John K. Davis, II has ... at the American Board of Internal Medicine (ABIM), effective ... will work closely with senior management and the Board ... operational oversight for the development and implementation of information ...
Cached Medicine News:Health News:User Centric Offers New Service, Usability Diagnostics, to Measure HIT Usability 2Health News:User Centric Offers New Service, Usability Diagnostics, to Measure HIT Usability 3Health News:Naturally fluorescent molecules may serve as cancer biomarker 2Health News:Naturally fluorescent molecules may serve as cancer biomarker 3Health News:CardioNet Expands Product Offering and Launches Clinical Research Services 2Health News:CardioNet Expands Product Offering and Launches Clinical Research Services 3Health News:CardioNet Expands Product Offering and Launches Clinical Research Services 4Health News:CardioNet Expands Product Offering and Launches Clinical Research Services 5Health News:CardioNet Expands Product Offering and Launches Clinical Research Services 6Health News:Trust for America's Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America 2Health News:Trust for America's Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America 3Health News:Horizon Blue Cross Blue Shield of New Jersey and CVS Caremark Reach 5.5 Million e-Prescriptions 2Health News:Horizon Blue Cross Blue Shield of New Jersey and CVS Caremark Reach 5.5 Million e-Prescriptions 3Health News:Horizon Blue Cross Blue Shield of New Jersey and CVS Caremark Reach 5.5 Million e-Prescriptions 4Health News:John K. Davis, II to Join the American Board of Internal Medicine as Chief Information Officer 2
Comfortable 3M hypoallergenic medical foam adhesive. Extra adhesive bandages for eye shield sets. 25 packages of 4 each....
Used with eye shield to cushion the eye. Eliminates need for taping shield. No sticky residue. Package 50 per box. White only....
Includes one aluminum Fox eye shield and one eye Garter shield cover. Packaged 50 per box. White only....
Adult size. Clear plastic. Accommodates either eye. Packaged 12 per box. Available in either adult or pediatric size....
Medicine Products: